ERGIC2 antibody (C-Term)
Quick Overview for ERGIC2 antibody (C-Term) (ABIN952104)
Target
See all ERGIC2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 334-362, C-Term
-
Specificity
- This antibody recognizes Human ERGIC2 (C-term).
-
Purification
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 334-362 amino acids from the C-terminal region of Human ERGIC2
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
-
Alternative Name
- ERGIC2
-
Background
- ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).Synonyms: CDA14, ERV41, Endoplasmic reticulum-Golgi intermediate compartment protein 2, PTX1
-
Molecular Weight
- 42549 Da
-
Gene ID
- 51290
-
NCBI Accession
- NP_057654
Target
-